Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer

Summary

Current therapies for Refractory Stage IV Prostate Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Refractory Stage IV Prostate Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Refractory Stage IV Prostate Cancer.

Timeline

Start

1996-10-11

Primary completion

1997-02-20

Completion

1997-02-20

Drugs

Indications